Severe acute respiratory syndrome (SARS): a review

By Vijayanand Pandurangan   Wilkins Ed   Woodhead Mark  

Clinical Medicine, Vol. 4, Iss. 2, 2004-03 ,pp. : 152-160

Royal College Of Physicians

Access to resources Recommend Favorite

Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy

By Barnard Dale L   Kumaki Yohichi  

Future Virology, Vol. 6, Iss. 5, 2011-05 ,pp. : 615-631

Future Medicine

Access to resources Recommend Favorite

Pharmacophores and biological activities of severe acute respiratory syndrome viral protease inhibitors

By Wang Hui-Min   Liang Po-Huang  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 533-546

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments in the Virology and Antiviral Research of Severe Acute Respiratory Syndrome Coronavirus

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 1, 2007-03 ,pp. : 29-41

Bentham Science Publishers

Access to resources Recommend Favorite

The US National Institute of Allergies and Infectious Diseases has granted $US10 million in funding to pharmaceutical company Baxter Healthcare to develop a vaccine against the coronavirus causing severe acute respiratory syndrome

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite